New pricing models for generic medicines to ensure long-term sustainable competition in Europe
Background: Price erosion of generic medicines over time as a result of existing pricing policies in combination with increasing operational costs of these products due to high inflation, undermine long-term sustainable competition in European off-patent medicines markets. Therefore, the aim of this...
Main Authors: | Clement Francois, Gabriela Gawlik, Jorge Mestre-Ferrandiz, Adrian Pana, Julian Perelman, John Yfantopoulos, Steven Simoens |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1200641/full |
Similar Items
-
Generic Medicine Pricing Policies in Europe: Current Status and Impact
by: Pieter Dylst, et al.
Published: (2010-03-01) -
How large are the differences between originator and generic prices? Analysis of five molecules in 16 European countries
by: Sabine Vogler
Published: (2012-12-01) -
Is greater generic competition also linked to lower drug prices in South Korea?
by: Kyung-Bok Son
Published: (2020-09-01) -
An empirical study of the impact of generic drug competition on drug market prices in China
by: Chen Yina, et al.
Published: (2023-05-01) -
How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing?
by: Dylst P, et al.
Published: (2012-03-01)